| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |